Dr. Mathew Blurton-Jones and Jean Paul Chadarevian were invited to share their research at this year’s ADPD 2025 (April 1-5) International Conference on Alzheimer’s and Parkinson’s Diseases.
Dr. Mathew Blurton-Jones was invited to moderate the session on cell replacement therapy & diagnostics, where he presented key findings highlighting the differences between CNS-wide engrafted human monocytes and iPSC-microglia. Dr. Jean Paul Chadarevian was also selected to present his research harnessing human iPSC-microglia for CNS-wide delivery of therapeutic peptides.
Congratulations to all the attendees and participants of ADPD 2025!
